6-hydroxy-nicotine-inducible multilevel transgene control in mammalian cells

Metabolic Engineering

Volumn 8, Issue 6, 2006, Pages 543-553

  Malphettes, Laetitia ^a   Schoenmakers, Ronald G ^a   Fussenegger, Martin ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

6 hydroxy nicotine; Heterologous gene regulation; Multicistronic expression; SAMY; SEAP; siRNA; Synthetic biology; VEGF

Indexed keywords

6-HYDROXY-NICOTINE; HETEROLOGOUS GENE REGULATION; MULTICISTRONIC EXPRESSION; SAMY; SEAP; SYNTHETIC BIOLOGY; VEGF;

BACTERIA; BIOCHEMICAL ENGINEERING; BIOTECHNOLOGY; CELLS; GENES; TISSUE;

GENETIC ENGINEERING;

6 HYDROXYNICOTINE; 6 HYDROXYNICOTINE OXIDASE; DNA DIRECTED RNA POLYMERASE III; ENZYME; KOX 1 PROTEIN; KRUEPPEL ASSOCIATED BOX PROTEIN; NICOTINE; PROTEIN; RNA POLYMERASE II; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTHROBACTER; ARTHROBACTER NICOTINOVORANS; ARTICLE; CELL STRAIN BHK; CHO CELL; CONTROLLED STUDY; FEMALE; FIBROSARCOMA; GENE EXPRESSION; GENETIC TRANSCRIPTION; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENE; VIRUS GENE;

ANIMALS; BIOTECHNOLOGY; CHO CELLS; CLONING, MOLECULAR; CRICETINAE; CRICETULUS; DNA-BINDING PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETIC ENGINEERING; GENETIC VECTORS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; NICOTINE; OXIDOREDUCTASES; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; SILENCER ELEMENTS, TRANSCRIPTIONAL; TRANSGENES;

ARTHROBACTER NICOTINOVORANS; CRICETINAE; CRICETULUS GRISEUS; MAMMALIA;

EID: 33749429153     PISSN: 10967176     EISSN: 10967184     Source Type: Journal    
DOI: 10.1016/j.ymben.2006.07.001     Document Type: Article

References (46)

1. Baitsch D., Sandu C., Brandsch R., and Igloi G.L. Gene cluster on pAO1 of Arthrobacter nicotinovorans involved in degradation of the plant alkaloid nicotine: cloning, purification, and characterization of 2,6-dihydroxypyridine 3-hydroxylase. J. Bacteriol. 183 (2001) 5262-5267
2. Brummelkamp T.R., Bernards R., and Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296 (2002) 550-553
3. Cohlan S.Q. Tetracycline staining of teeth. Teratology 15 (1977) 127-129
4. Folcher M., Gaillard H., Nguyen L.T., Nguyen K.T., Lacroix P., Bamas-Jacques N., Rinkel M., and Thompson C.J. Pleiotropic functions of a Streptomyces pristinaespiralis autoregulator receptor in development, antibiotic biosynthesis, and expression of a superoxide dismutase. J. Biol. Chem. 276 (2001) 44297-44306
5. Fussenegger M. The impact of mammalian gene regulation concepts on functional genomic research, metabolic engineering, and advanced gene therapies. Biotechnol. Prog. 17 (2001) 1-51
6. Fussenegger M., Mazur X., and Bailey J.E. pTRIDENT, a novel vector family for tricistronic gene expression in mammalian cells. Biotechnol. Bioeng. 57 (1998) 1-10
7. Fussenegger M., Schlatter S., Datwyler D., Mazur X., and Bailey J.E. Controlled proliferation by multigene metabolic engineering enhances the productivity of Chinese hamster ovary cells. Nat. Biotechnol. 16 (1998) 468-472
8. Fussenegger M., Bailey J.E., and Varner J. A mathematical model of caspase function in apoptosis. Nat. Biotechnol. 18 (2000) 768-774
9. Fux C., Langer D., and Fussenegger M. Dual-regulated myoD- and msx1-based interventions in C2C12-derived cells enable precise myogenic/osteogenic/adipogenic lineage control. J. Gene Med. 6 (2004) 1159-1169
10. Fux C., Langer D., Kelm J.M., Weber W., and Fussenegger M. New-generation multicistronic expression platform: pTRIDENT vectors containing size-optimized IRES elements enable homing endonuclease-based cistron swapping into lentiviral expression vectors. Biotechnol. Bioeng. 86 (2004) 174-187
11. Fux C., Mitta B., Kramer B.P., and Fussenegger M. Dual-regulated expression of C/EBP-alpha and BMP-2 enables differential differentiation of C2C12 cells into adipocytes and osteoblasts. Nucl. Acids. Res. 32 (2004) e1
12. Grether-Beck S., Igloi G.L., Pust S., Schilz E., Decker K., and Brandsch R. Structural analysis and molybdenum-dependent expression of the pAO1-encoded nicotine dehydrogenase genes of Arthrobacter nicotinovorans. Mol. Microbiol. 13 (1994) 929-936
13. Hannon G.J., and Rossi J.J. Unlocking the potential of the human genome with RNA interference. Nature 431 (2004) 371-378
14. Hartenbach S., and Fussenegger M. Autoregulated, bidirectional and multicistronic gas-inducible mammalian as well as lentiviral expression vectors. J. Biotechnol. 120 (2005) 83-98
15. Kramer B.P., and Fussenegger M. Hysteresis in a synthetic mammalian gene network. Proc. Natl. Acad. Sci. USA 102 (2005) 9517-9522
16. Kramer B.P., Weber W., and Fussenegger M. Artificial regulatory networks and cascades for discrete multilevel transgene control in mammalian cells. Biotechnol. Bioeng. 83 (2003) 810-820
17. Kramer B.P., Fischer C., and Fussenegger M. BioLogic gates enable logical transcription control in mammalian cells. Biotechnol Bioeng 87 (2004) 478-484
18. Kramer B.P., Viretta A.U., Daoud-El-Baba M., Aubel D., Weber W., and Fussenegger M. An engineered epigenetic transgene switch in mammalian cells. Nat. Biotechnol. 22 (2004) 867-870
19. Latli B., D'Amour K., and Casida J.E. Novel and potent 6-chloro-3-pyridinyl ligands for the alpha4beta2 neuronal nicotinic acetylcholine receptor. J. Med. Chem. 42 (1999) 2227-2234
20. Lautermann J., Dehne N., Schacht J., and Jahnke K. Aminoglycoside- and cisplatin-ototoxicity: from basic science to clinics. Laryngorhinootologie 83 (2004) 317-323
21. Malphettes L., and Fussenegger M. Macrolide- and tetracycline-adjustable siRNA-mediated gene silencing in mammalian cells using polymerase II-dependent promoter derivatives. Biotechnol. Bioeng. 88 (2004) 417-425
22. Malphettes, L., Fussenegger, M., 2006. Improved transgene expression fine-tuning in mammalian cells using a novel transcription-translation network. J. Biotechnol.
23. Malphettes L., Weber C.C., El-Baba M.D., Schoenmakers R.G., Aubel D., Weber W., and Fussenegger M. A novel mammalian expression system derived from components coordinating nicotine degradation in Arthrobacter nicotinovorans pAO1. Nucl. Acids. Res. 33 (2005) e107
24. Meents H., Enenkel B., Eppenberger H.M., Werner R.G., and Fussenegger M. Impact of coexpression and coamplification of sICAM and antiapoptosis determinants bcl-2/bcl-x(L) on productivity, cell survival, and mitochondria number in CHO-DG44 grown in suspension and serum-free media. Biotechnol. Bioeng. 80 (2002) 706-716
25. Meents H., Enenkel B., Werner R.G., and Fussenegger M. p27Kip1-mediated controlled proliferation technology increases constitutive sICAM production in CHO-DUKX adapted for growth in suspension and serum-free media. Biotechnol. Bioeng. 79 (2002) 619-627
26. Moosmann P., Georgiev O., Thiesen H.J., Hagmann M., and Schaffner W. Silencing of RNA polymerases II and III-dependent transcription by the KRAB protein domain of KOX1, a Kruppel-type zinc finger factor. Biol. Chem. 378 (1997) 669-677
27. Moser S., Schlatter S., Fux C., Rimann M., Bailey J.E., and Fussenegger M. An update of pTRIDENT multicistronic expression vectors: pTRIDENTs containing novel streptogramin-responsive promoters. Biotechnol. Prog. 16 (2000) 724-735
28. Pollok K.E., Hartwell J.R., Braber A., Cooper R.J., Jansen M., Ragg S., Bailey B.J., Erickson L.C., Kreklau E.L., and Williams D.A. In vivo selection of human hematopoietic cells in a xenograft model using combined pharmacologic and genetic manipulations. Hum. Gene Ther. 14 (2003) 1703-1714
29. Prati E.G., Matasci M., Suter T.B., Dinter A., Sburlati A.R., and Bailey J.E. Engineering of coordinated up- and down-regulation of two glycosyltransferases of the O-glycosylation pathway in Chinese hamster ovary (CHO) cells. Biotechnol. Bioeng. 68 (2000) 239-244
30. Prati E.G., Matasci M., Suter T.B., Dinter A., Sburlati A.R., and Bailey J.E. Engineering of coordinated up- and down-regulation of two glycosyltransferases of the O-glycosylation pathway in Chinese hamster ovary (CHO) cells. Biotechnol. Bioeng. 79 (2002) 580-585
31. Roduit J.P., Wellig A., and Kiener A. Renewable functionalized pyridines derived from microbial metabolites of the alkaloid (S)-nicotine. Heterocycles 45 (1997) 1687-1702
32. Sandu C., Chiribau C.B., and Brandsch R. Characterization of HdnoR, the transcriptional repressor of the 6-hydroxy-D-nicotine oxidase gene of Arthrobacter nicotinovorans pAO1, and its DNA-binding activity in response to l- and d-nicotine derivatives. J. Biol. Chem. 278 (2003) 51307-51315
33. Sartor O., and Cutler Jr. G.B. Mifepristone: treatment of Cushing's syndrome. Clin. Obstet. Gynecol. 39 (1996) 506-510
34. Schlatter S., Rimann M., Kelm J., and Fussenegger M. SAMY, a novel mammalian reporter gene derived from Bacillus stearothermophilus alpha-amylase. Gene 282 (2002) 19-31
35. Stegmeier F., Hu G., Rickles R.J., Hannon G.J., and Elledge S.J. A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. Proc. Natl. Acad. Sci. USA 102 (2005) 13212-13217
36. Toniatti C., Bujard H., Cortese R., and Ciliberto G. Gene therapy progress and prospects: transcription regulatory systems. Gene Ther. 11 (2004) 649-657
37. Tschitschibabin A.E., and Kirssanow A.W. Aminierung des Niotins mit Natrium- und Kaliumamid. Ber. Dtsch. Chem. Ges. 57 (1924) 1163-1168
38. Vallier L., Mancip J., Markossian S., Lukaszewicz A., Dehay C., Metzger D., Chambon P., Samarut J., and Savatier P. An efficient system for conditional gene expression in embryonic stem cells and in their in vitro and in vivo differentiated derivatives. Proc. Natl. Acad. Sci. USA 98 (2001) 2467-2472
39. Weber, W., Fussenegger, M., 2006. Pharmacologic transgene control systems for gene therapy. J. Gene. Med.
40. Weber W., Fux C., Daoud-el Baba M., Keller B., Weber C.C., Kramer B.P., Heinzen C., Aubel D., Bailey J.E., and Fussenegger M. Macrolide-based transgene control in mammalian cells and mice. Nat. Biotechnol. 20 (2002) 901-907
41. Weber W., Kramer B.P., Fux C., Keller B., and Fussenegger M. Novel promoter/transactivator configurations for macrolide- and streptogramin-responsive transgene expression in mammalian cells. J. Gene Med. 4 (2002) 676-686
42. Weber W., Rimann M., de Glutz F.N., Weber E., Memmert K., and Fussenegger M. Gas-inducible product gene expression in bioreactors. Metab. Eng. 7 (2005) 174-181
43. Weber W., Schoenmakers R., Spielmann M., El-Baba M.D., Folcher M., Keller B., Weber C.C., Link N., van de Wetering P., Heinzen C., and others. Streptomyces-derived quorum-sensing systems engineered for adjustable transgene expression in mammalian cells and mice. Nucl. Acids. Res. 31 (2003) e71
44. Xia H., Mao Q., Paulson H.L., and Davidson B.L. siRNA-mediated gene silencing in vitro and in vivo. Nat. Biotechnol. 20 (2002) 1006-1010
45. Yang L., and Baltimore D. Long-term in vivo provision of antigen-specific T cell immunity by programming hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 102 (2005) 4518-4523
46. Yen L., Svendsen J., Lee J.S., Gray J.T., Magnier M., Baba T., D'Amato R.J., and Mulligan R.C. Exogenous control of mammalian gene expression through modulation of RNA self-cleavage. Nature 431 (2004) 471-476